SUBSCRIBERS
Valeant leads the way in steep price increase of skin drugs
Published Fri, Nov 27, 2015 · 09:50 PM
New York
TWO drugs sold by Valeant Pharmaceuticals International to treat cancer-related skin conditions increased in price by about 1,700 per cent over the last six years, according to a newly published survey that found big increases in the cost of dermatology drugs across the board.
Overall, retail prices of 19 brand-name dermatology drugs from various manufacturers, for …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
France's Casino supermarket chain to axe up to 3,200 jobs
Prada’s sales up 16% in first quarter as Miu Miu shines
Toymaker Hasbro posts quarterly profit beat, slower sales decline
Hilton lifts 2024 profit forecast on international travel demand
China knockoff raid jolts a global throng of fake-fashion influencers
Roche cuts pipeline after research setbacks and sales drop